MedPath
HSA Product

IBERET-FOLIC-500 TABLET

Product approved by Health Sciences Authority (SG)

Basic Information

IBERET-FOLIC-500 TABLET

TABLET, FILM COATED

Regulatory Information

SIN05447P

February 19, 1991

General Sale List

Therapeutic

ORAL

August 10, 2023

May 30, 2025

XB03AE02

Company Information

ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED

ABBOTT LABORATORIES (SINGAPORE) PRIVATE LIMITED

Active Ingredients

Detailed Information

Contraindications

**WHEN SHOULD YOU NOT TAKE THIS MEDICINE?** Known sensitivity to any of its ingredients. Repeated blood transfusions or parenteral iron therapy contraindicate concurrent oral iron therapy. Iberet Folic 500 is contraindicated in the rare instance of hypersensitivity to folic acid and in patients with pernicious anaemia.

Indication Information

**WHAT IS THIS MEDICINE USED FOR?** Iberet Folic 500 is indicated in non-pregnant adults for treatment of iron deficiency and prevention of concomitant folic acid deficiency where there is an associated deficient intake or increased need for the B-complex vitamins. Iberet Folic 500 is also indicated in pregnancy for the prevention and treatment of iron deficiency where there is a concomitant deficient intake or increased need for the B-complex vitamins (including folic acid).

© Copyright 2025. All Rights Reserved by MedPath